P0458 Impact of histological subtype and metastatic burden on overall survival after cytoreductive nephrectomy for metastatic RCC in the immunotherapy era: Insights from the National Cancer Database

European Urology 2026

View at publisher
Authors: G. Garofano, C. Saitta, G. Fontana, G. Musso, EDWARD CHERULLO, S. Vourganti, Mai Dabbas, Umberto Capitanio A, Francesco Montorsi, Giovanni Lughezzani A, P. Casale, N.M. Buffi
+1 more I.H. Derweesh
DOI: 10.1016/s0302-2838(26)01345-x
Cited by: 0

Fields of Study & Subjects

Renal cell carcinoma treatment Bladder and Urothelial Cancer Treatments Cancer Immunotherapy and Biomarkers

Publication details

Journal / source
European Urology
Volume
89
Pages
S1–S1
Publication date
13 February 2026
Language
EN